Binding of peanut lectin to breast epithelium, human carcinomas, and a cultured rat mammary stem cell: use of the lectin as a marker of mammary differentiation.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 292805)

Published in J Natl Cancer Inst on December 01, 1979

Authors

R A Newman, P J Klein, P S Rudland

Articles citing this

Extracellular matrix promotes mammary epithelial growth and differentiation in vitro. Proc Natl Acad Sci U S A (1982) 2.72

Alterations in human colonic mucin occurring with cellular differentiation and malignant transformation. Proc Natl Acad Sci U S A (1982) 2.17

Glycoprotein abnormalities in colonic carcinomata, adenomata, and hyperplastic polyps shown by lectin peroxidase histochemistry. J Clin Pathol (1986) 1.11

Stem cells in rat mammary development and cancer: a review. J R Soc Med (1980) 1.10

Sequential alteration of peanut agglutinin binding-glycoprotein expression during progression of murine mammary neoplasia. Br J Cancer (1992) 1.06

Expression of binding sites for peanut agglutinin during murine B lymphocyte differentiation. Immunology (1980) 1.00

Uptake of choline by rat mammary-gland epithelial cells. Biochem J (1988) 0.97

Rat and human mammary tissue can synthesize choline moiety via the methylation of phosphatidylethanolamine. Biochem J (1988) 0.92

Differences in lectin binding in tissue sections of human and murine malignant tumors and their metastases. Am J Pathol (1985) 0.89

Isolation and chemical and immunochemical characterization of the peanut-lectin-binding glycoprotein from human milk-fat-globule membranes. Biochem J (1984) 0.83

Analysis of the peanut agglutinin-binding site as a differentiation marker of normal and malignant human lymphoid cells. Clin Exp Immunol (1981) 0.82

Differences in cellular glycoconjugates of quiescent, inflamed, and neoplastic colonic epithelium in colitis and cancer-prone tamarins. Am J Pathol (1988) 0.80

Localization and significance of peanut agglutinin-binding sites on ependymoma cells. Acta Neuropathol (1990) 0.78

Lectin binding to serous ovarian tumours. J Clin Pathol (1988) 0.76

Use of immunohistochemical staining panel for characterisation of ovarian neoplasms. J Clin Pathol (1988) 0.76

Modulation of mammary development and programmed cell death by the frequency of milk removal in lactating goats. J Physiol (1999) 0.76

Lectin binding by liver and lung metastasizing variants of the murine Lewis lung carcinoma. Am J Pathol (1988) 0.75

Thyroid and mammary radiobiology: radiogenic damage to glandular tissue. Br J Cancer Suppl (1986) 0.75

Differentiation of mammary stem cells in vivo and in vitro. Environ Health Perspect (1989) 0.75

Articles by these authors

A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem (1982) 6.70

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood (1994) 6.47

A possible mammary stem cell line. Cell (1978) 2.19

Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res (1982) 2.07

Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration. Surgery (1993) 2.01

Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. Oncogene (1993) 1.99

Possible involvement of cyclic GMP in growth control of cultured mouse cells. Nature (1974) 1.96

Anvirzel, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anticancer Drugs (2000) 1.95

Growth control in cultured mouse fibroblasts: induction of the pleiotypic and mitogenic responses by a purified growth factor. Proc Natl Acad Sci U S A (1974) 1.93

Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. Cancer Res (2000) 1.69

Control of translation by T4 phage: altered binding of disfavoured messengers. Nature (1970) 1.54

Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood (1983) 1.54

Initiation of cell proliferation in cultured mouse fibroblasts by prostaglandin F2alpha. Proc Natl Acad Sci U S A (1975) 1.52

Iron salts and transferrin are specifically required for cell division of cultured 3T6 cells. Biochem Biophys Res Commun (1977) 1.51

Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. Cancer Res (1998) 1.51

Stem cells and the development of mammary cancers in experimental rats and in humans. Cancer Metastasis Rev (1987) 1.45

Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours. Oncogene (1996) 1.45

15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells. J Natl Cancer Inst (2000) 1.43

Changes in RNA metabolism and accumulation of presumptive messenger RNA during transition from the growing to the quiescent state of cultured mouse fibroblasts. J Mol Biol (1975) 1.39

Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Anal Biochem (2001) 1.38

The biochemical characterization of a cell surface antigen associated with acute lymphoblastic leukemia and lymphocyte precursors. J Immunol (1981) 1.36

The long term prognostic significance of c-erbB-2 in primary breast cancer. Br J Cancer (1991) 1.35

Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anat Histopathol (1986) 1.35

Transferrin receptors: structure and function. Biochem Pharmacol (1984) 1.34

Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res (2000) 1.33

Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol (2001) 1.33

[Comparative in vivo- and in vitro-determination of the cell proliferation kinetics of experimental tumors and the estimation of the cell cycle of human tumor cells in vitro (author's transl)]. Verh Dtsch Ges Pathol (1971) 1.32

Control of translation in cultured cells: continued synthesis and accumulation of messenger RNA in nondividing cultures. Proc Natl Acad Sci U S A (1974) 1.32

15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. Cancer Res (2000) 1.31

Biodistribution of paclitaxel and poly(L-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor. Cancer Chemother Pharmacol (2000) 1.31

Increased expression of anterior gradient-2 is significantly associated with poor survival of prostate cancer patients. Prostate Cancer Prostatic Dis (2007) 1.29

Control of translation of T4 phage: altered ribosome binding at R17 initiation sites. Nature (1970) 1.28

Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. Br J Cancer (2006) 1.26

Cyclic GMP and cyclic AMP levels in normal and transformed fibroblasts. Nature (1974) 1.25

A structural requirement for codon-anticodon interaction on the ribosome. Cold Spring Harb Symp Quant Biol (1969) 1.23

8-chloro-cAMP and 8-chloro-adenosine act by the same mechanism in multiple myeloma cells. Cancer Res (2001) 1.22

Characterization of glycoconjugates of human gastrointestinal mucosa by lectins. I. Histochemical distribution of lectin binding sites in normal alimentary tract as well as in benign and malignant gastric neoplasms. J Histochem Cytochem (1984) 1.20

Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome. Lancet (1977) 1.19

Developmental changes in the specificity of memory over the first year of life. Dev Psychobiol (1998) 1.19

The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis (1997) 1.19

Rat epidermal growth factor: complete amino acid sequence. Homology with the corresponding murine and human proteins; isolation of a form truncated at both ends with full in vitro biological activity. Eur J Biochem (1985) 1.19

Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARdelta/PGE2 and elevation of PGE3. Carcinogenesis (2007) 1.19

Activation of guanyl cyclase and intracellular cyclic GMP by fibroblast growth factor. Nature (1974) 1.18

The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene (1996) 1.18

Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells. Oncogene (1998) 1.17

Action of growth factors in the cell cycle. Biochim Biophys Acta (1979) 1.17

Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer. Int J Cancer (2000) 1.16

Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br J Cancer (1994) 1.15

Molecular cloning and sequence of the gene for p9Ka. A cultured myoepithelial cell protein with strong homology to S-100, a calcium-binding protein. J Mol Biol (1987) 1.14

Differential expression of HLA-DR and DR-linked determinants on human leukemias and lymphoid cells. Eur J Immunol (1983) 1.13

Phase I trial of Taxotere: five-day schedule. J Natl Cancer Inst (1992) 1.12

Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res (2001) 1.11

S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. Br J Cancer (2004) 1.11

S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes. Br J Cancer (2002) 1.10

Stem cells in rat mammary development and cancer: a review. J R Soc Med (1980) 1.10

Fibroblast growth factor-2 stimulation of p42/44MAPK phosphorylation and IkappaB degradation is regulated by heparan sulfate/heparin in rat mammary fibroblasts. J Biol Chem (2000) 1.10

Interaction of heparan sulfate from mammary cells with acidic fibroblast growth factor (FGF) and basic FGF. Regulation of the activity of basic FGF by high and low affinity binding sites in heparan sulfate. J Biol Chem (1998) 1.10

Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin. Biochem Pharmacol (2001) 1.09

Modulation of T leukaemic cell phenotype with phorbol ester. Int J Cancer (1982) 1.09

Binding to intracellular targets of the metastasis-inducing protein, S100A4 (p9Ka). Biochem Biophys Res Commun (2001) 1.09

Comparison of the effects of hormones on DNA synthesis in cell cultures of nonneoplastic and neoplastic mammary epithelium from rats. Cancer Res (1977) 1.09

Mitogenic activity of pituitary hormones on cell cultures of normal and carcinogen-induced tumor epithelium from rat mammary glands. J Cell Biol (1977) 1.07

Recognition of bacterial initiator tRNA by an initiation factor. Nat New Biol (1971) 1.06

Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A. Ann N Y Acad Sci (2008) 1.06

Temporal sequence of hormonal interactions during the prereplicative phase of quiescent cultured 3T3 fibroblasts. Proc Natl Acad Sci U S A (1977) 1.05

Breast implants and cancer: causation, delayed detection, and survival. Plast Reconstr Surg (2001) 1.05

Histochemical methods for the demonstration of Thomsen-Friedenreich antigen in cell suspensions and tissue sections. Klin Wochenschr (1978) 1.05

Topographical arrangement of basement membrane proteins in lactating rat mammary gland: comparison of the distribution of type IV collagen, laminin, fibronectin, and Thy-1 at the ultrastructural level. Proc Natl Acad Sci U S A (1983) 1.04

Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4. Cancer Res (2001) 1.02

RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin. Oncogene (2008) 1.02

Prognostic significance of cathepsin-D in patients with breast cancer. Br J Cancer (1993) 1.02

Expression of calcium-binding protein S100A2 in breast lesions. Br J Cancer (2000) 1.01

Characterization of a myoepithelial cell line derived from a neonatal rat mammary gland. J Cell Biol (1981) 1.01

Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1. J Biol Chem (2000) 1.01

Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer. Cancer Res (2000) 1.00

Expression of binding sites for peanut agglutinin during murine B lymphocyte differentiation. Immunology (1980) 1.00

Ribosomal binding of bacteriophage RNA with different components of initiation factor F3. J Mol Biol (1972) 1.00

Distribution of entactin in the basement membrane of the rat mammary gland. Evidence for a non-epithelial origin. Exp Cell Res (1984) 1.00

Adhesion promoters, their effect on the bond strength of metal brackets. Am J Orthod Dentofacial Orthop (1995) 0.99

Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Cancer Res (1986) 0.99

Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens. Int J Cancer (2000) 0.99

Cyclic nucleotides and growth control in cultured mouse cells: correlation of changes in intracellular 3':5' cGMP concentration with a specific phase of the cell cycle. Proc Natl Acad Sci U S A (1974) 0.99

Transgenic expression of 15-lipoxygenase 2 (15-LOX2) in mouse prostate leads to hyperplasia and cell senescence. Oncogene (2010) 0.98

Phenotypic instability of rat mammary tumor epithelial cells. J Natl Cancer Inst (1983) 0.98

Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer. Cancer Chemother Pharmacol (1996) 0.98

Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer. J Clin Oncol (1996) 0.98

Cytoplasmic staining of c-erbB-2 is not associated with the presence of detectable c-erbB-2 mRNA in breast cancer specimens. Int J Cancer (1998) 0.98

[Therapeutically induced form of reno-cerebral oxalosis? (author's transl)]. Acta Neuropathol (1974) 0.97

Stability of different ribosomal complexes with initiator transfer RNA and synthetic messenger RNA. J Mol Biol (1969) 0.96

Caspase-dependent apoptosis induced by telomere cleavage and TRF2 loss. Neoplasia (2001) 0.96

Immunocytochemical distribution of the calcium-binding protein p9Ka in normal rat tissues: variation in the cellular location in different tissues. J Histochem Cytochem (1995) 0.96

Rat mammary preadipocytes in culture produce a trophic agent for mammary epithelia-prostaglandin E2. J Cell Physiol (1984) 0.96

Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study. Ann Surg Oncol (1994) 0.95

Histochemical demonstration of neuraminidase effects in pneumococcal meningitis. Lab Invest (1983) 0.95

Novel DNA groove binding alkylators: design, synthesis, and biological evaluation. J Med Chem (1988) 0.95

Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog. Science (1985) 0.95

Clinical toxicologic and pharmacologic studies of gallium nitrate. Cancer (1979) 0.95

15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma. Oncogene (2006) 0.95